Vectorite Biomedical Inc. (TPEX:4170)
Taiwan · Delayed Price · Currency is TWD 13.95
+0.10 (0.72%)
Feb 11, 2026, 2:59 PM CST
Vectorite Biomedical Market Cap
Vectorite Biomedical has a market cap or net worth of 610.61 million as of February 11, 2026. Its market cap has decreased by -1.06% in one year.
Market Cap
610.61M
Enterprise Value
434.75M
Revenue
67.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
13.95
Market Cap Chart
Since April 15, 2013, Vectorite Biomedical's market cap has increased from 393.23M to 610.61M, an increase of 55.28%. That is a compound annual growth rate of 3.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 610.61M | -0.36% |
| Dec 31, 2025 | 612.80M | -3.45% |
| Dec 31, 2024 | 634.68M | -32.08% |
| Dec 29, 2023 | 934.52M | 49.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lukas Biomedical | 1.21B |
| Holy Stone Healthcare | 1.17B |
| Neith | 1.16B |
| Level Biotechnology | 1.06B |
| TCI GENE | 1.01B |
| Eusol Biotech | 993.25M |
| Taiwan Advance Bio-Pharmaceutical | 990.00M |
| NatureWise Biotech & Medicals | 909.50M |